![Denovo Biopharma](https://gocience.com/logos/new/76c9e9f0e2e78adffe0bfa3c95a1ac1b5a5109c486b1389a5845d850924b07b4.jpg)
Denovo Biopharma
Biotechnology, Science Center Dr, San Diego, , 92121, California, 10240, United States, 11-50 Employees
Phone Number: 85********
Who is DENOVO BIOPHARMA
A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker ...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 10240 Science Center Dr, San Diego, California, 92121, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from DENOVO BIOPHARMA
Denovo Biopharma Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Denovo Biopharma
Answer: Denovo Biopharma's headquarters are located at Science Center Dr, San Diego, , 92121, California, 10240, United States
Answer: Denovo Biopharma's phone number is 85********
Answer: Denovo Biopharma's official website is https://denovobiopharma.com
Answer: Denovo Biopharma's revenue is $25 Million to $50 Million
Answer: Denovo Biopharma's SIC: 2834
Answer: Denovo Biopharma's NAICS: 325412
Answer: Denovo Biopharma has 11-50 employees
Answer: Denovo Biopharma is in Biotechnology
Answer: Denovo Biopharma contact info: Phone number: 85******** Website: https://denovobiopharma.com
Answer: A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effects. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in most therapeutic areas, such as oncology and neurological diseases.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month